Lord, Abbett & Co’s Insmed INSM Stock Holding History

Lord, Abbett & Co’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-68,000	Closed	-$611K	–	577
2025 Q3	$611K	Sell	68,000 -65,000	-49%	-$7.96M	﹤0.01%	521
2025 Q2	$569K	Buy	+133,000	New	+$10.2M	﹤0.01%	506

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Lord, Abbett & Co's INSM Position: Q2 2026 in Review

Lord, Abbett & Co sold out of Insmed (INSM) in Q2 2026, closing a stake of 397,261 shares — an estimated $65M sold.

Lord, Abbett & Co first reported a position in INSM in Q1 2014 and held it in 27 quarters. The position peaked at $208M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Lord, Abbett & Co reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Lord, Abbett & Co sold 397,261 Insmed shares in Q2 2026, an estimated $65M.
Lord, Abbett & Co first reported a position in Insmed in Q1 2014 and held it in 27 quarters.
Lord, Abbett & Co's Insmed position peaked at $208M in Q3 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.